arrow_back Civic Audit
Share share

Enhanced Cancer Screening for Communities: Breast and Cervical Cancer Act

This act reauthorizes and improves the National Breast and Cervical Cancer Early Detection Program, ensuring access to screening and diagnostic services. The changes aim to reduce health disparities and increase early cancer detection.
Key points
Authorizes funding for the breast and cervical cancer early detection program at $500 million annually for fiscal years 2023-2027.
Expands program services to include prevention activities, patient navigation, and care coordination.
Focuses on reducing disparities in breast and cervical cancer incidence and mortality in populations with higher than average rates.
Improves equitable access to screening and diagnostic services for individuals facing additional barriers, including social determinants of health.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_8185
Sponsor: Rep. Morelle, Joseph D. [D-NY-25]
Process start date: 2022-06-22
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

SCREENS for Cancer Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_8185.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-06-22.

What are the main provisions?

Key points include:

  • Authorizes funding for the breast and cervical cancer early detection program at $500 million annually for fiscal years 2023-2027.
  • Expands program services to include prevention activities, patient navigation, and care coordination.
  • Focuses on reducing disparities in breast and cervical cancer incidence and mortality in populations with higher than average rates.
  • Improves equitable access to screening and diagnostic services for individuals facing additional barriers, including social determinants of health.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Morelle, Joseph D. [D-NY-25].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health